Pharma faces regulations and stringent rules for transparency, but the payoff is drugs that can get to market faster and ...

HLP003 (previously referred to as CYB003): a proprietary NSA, in Phase 3 clinical development for the adjunctive treatment of major depressive disorder that has received Breakthrough Therapy ...

LGM Pharma’s Expanded Contract Development and Manufacturing Organization (CDMO) Capabilities Will Enable Customers to Accelerate and Optimize the New Product Pathway from Early Development Through ...

ST. GALLEN, Switzerland & PALMA, Spain & ZURICH--(BUSINESS WIRE)--Regulatory News: “We are gaining momentum with our ambitious strategic growth plans as we today add Sanifit, Inositec and their ...

Sophie Lamle brings over 20 years of experience in the pharmaceutical industry, leading innovation, clinical development, and strategic transformation. Her appointment will further strengthen LEO ...

Partnerships in healthcare have never been more important. Through collaboration, industry specialists are increasingly bringing cutting-edge medical innovations and life-changing treatments to ...

Medicus Pharma Ltd ( ($MDCX) ) just unveiled an update. Medicus Pharma will present at Biotech Showcase 2026 in San Francisco as it enters the ...

Silo Pharma, Inc., a biopharmaceutical company focused on developing innovative treatments for mental health and chronic pain, announced in a recent letter to shareholders that it expects to submit an ...

Akums Drugs & Pharma and Sharda University signed an MoU to collaborate on pharma research, technology transfer, skill ...

Royalty Pharma plc has completed a transaction to monetize remaining fixed payments on the MorphoSys Development Funding Bonds for $511 million in cash, resulting in total proceeds of $530 million ...

Sterling Pharma Solutions will spend $13 million to add process development labs and commercial-scale manufacturing equipment for pharmaceutical chemicals at its site in Dudley, England. The project ...

Donna Conroy, MS is Founder/CEO of SciMar ONE, Inc. a technology company building AI-based SaaS solutions for the pharmaceutical industry. Investing time and resources is clearly a long-term strategy ...